Abstract:In the crystal structure of the title compound, C(22)H(17)BrO(6), quinone ring makes a dihedral angle of 81.84 (3)degrees with benzene ring. The chiral C atoms, viz. the ring C atoms the hydroxy and bromophenyl substituents, exhibit R and S configurations, respectively. The terminal ethyl group of -CO(2)CH(2)CH(3) group is disordered over two sets of sites site-occupancy factors of 0.64 (1) and 0.36 (1). O-H center dot center dot center dot O interactions further stabilize the crystal packing.

1,2-Bis(4-methoxyphenoxy)ethane

(4-Tert-butylphenyl)acetic Acid

(E)-4-chloro-2-{[4-(3,5-dichloro-pyridin-2-yl-oxy)phenyl-imino]-meth-yl}phenol.

(E)-3-(4-Hydroxyphenyl)-1-(4-methoxy-phenyl)prop-2-en-1-one

Ethyl (4ar,7s,8s,8as)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

(E)-1-(4-chlorophenyl)-3-(4-methoxyphenyl)-prop-2-en-1-one

(E)-3-(4-Hydroxyphenyl)-1-(4-Methoxyphenyl) Prop-2-En-1-One

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

exo-4-[(1H-Benzimidazol-2-yl)meth-yl]-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

(E)-1-(diphenylphosphinyl)-2-(1-hydroxycyclohexyl)ethene

Exo-4-[(1H-Benzimidazol-2-yl)methyl]-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

1,3-Bis(1h-benzimidazol-2-yl)-2-oxa-propane

N&#8242;-[1-(4-Chlorophenyl)ethylidene]benzohydrazide

Methyl 2-[2-(6-Chloro-pyrimidin-4-yl-oxy)phen-yl]-3,3-dimethoxy-propanoate.

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

Ethyl (2s,4r)-4-(4-Bromophenyl)-2-Hydroxy-5,10-Dioxo-3,4,5,10-Tetrahydro-2h-Be Nzo[G]Chromene-2-Carboxylate

1-(1-Tosyl-1H-pyrrol-2-yl)ethanone

Ethyl 4-(4-Chloro-phen-yl)-2-methyl-5-oxo-5,6,7,8-tetra-hydro-quinoline-3-carboxyl-ate.

N-[2-(2-Methoxyphenyl)benzylidene]-tert-butyl-amine N-oxide.

3-[4-(Benz-yloxy)phen-yl]-1-(2-fur-yl)-3-hydroxy-prop-2-en-1-one.